Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy

References

• Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4:43.
   PubMed Web of Science ®Google Scholar
• Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci. 2011;34:581–590.
   PubMed Web of Science ®Google Scholar
• Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–269.
   PubMed Web of Science ®Google Scholar
• Finke C, Siebert E, Plotkin M, et al. Multiple system atrophy masking multiple sclerosis. Clin Neurol Neurosurg. 2010;112:59–61.
   PubMed Web of Science ®Google Scholar
• Jellinger KA, Wenning GK. Overlaps between multiple system atrophy and multiple sclerosis: a novel perspective. Mov Disord. 2016;31:1767–1771.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Ho G, Takamatsu Y, et al. Evolvability and Neurodegenerative Disease: antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates. J Parkinsons Dis. 2018;8:405–408.
   PubMedGoogle Scholar
• Wei J, Ho G, Takamatsu Y, et al. Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease. Parkinson’s Dis. 2021;2021:6318067.
   PubMedGoogle Scholar
• Hashimoto M, Ho G, Takamatsu Y, et al. Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability. Prion. 2020;14:1–8.
   PubMed Web of Science ®Google Scholar
• Roan NR, Sandi-Monroy N, Kohgadai N, et al. Semen amyloids participate in spermatozoa selection and clearance. eLife. 2017;6:5.
   Web of Science ®Google Scholar
• National Toxicology Program. Ovary - Amyloid - Nonneoplastic Lesion Atlas (nih.gov). Maryland: U.S. Department of Health and Human Services; 2017.
   Google Scholar
• Chernoff YO. Mutation processes at the protein level: is Lamarck back? Mutat Res. 2001;488:39–64.
   PubMed Web of Science ®Google Scholar
• Nalls AV, McNulty E, Powers J, et al. Mother to offspring transmission of chronic wasting disease in reeves’ muntjac deer. PloS one. 2013;8:e71844.
   PubMed Web of Science ®Google Scholar
• Castilla J, Brun A, Díaz-San Segundo F, et al. Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model. J Virol. 2005;79:8665–8668.
   PubMed Web of Science ®Google Scholar
• Goedert M, Masuda-Suzukake M, Falcon B. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration. Brain. 2017;140:266–278.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Rockenstein E, Mante M, et al. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron. 2001;32:213–223.
   PubMed Web of Science ®Google Scholar
• Lodygin D, Hermann M, Schweingruber N, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503–508.
   PubMed Web of Science ®Google Scholar
• Fujita M, Sugama S, Sekiyama K, et al. A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain. Nat Commun. 2010;1:110.
   PubMed Web of Science ®Google Scholar
• Halbgebauer S, Oeckl P, Steinacker P, et al., Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease. 2021;J Nerol Neurosurg Psychiatry. 92:349–356.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Bar-On P, Ho G, et al. β-Synuclein Regulates Akt Activity in Neuronal Cells a possible mechanism for neuroprotection in Parkinsons disease. J Biol Chem. 2004;279:23622–23629.
   PubMed Web of Science ®Google Scholar
• Masliah E, Rockenstein E, Adame A, et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson’s disease. Neuron. 2005;46:857–868.
   PubMed Web of Science ®Google Scholar
• Antonelou R, Emmanouilidou E, Gasparinatos G, et al. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis. J Neurochem. 2015;134:748–755.
   PubMed Web of Science ®Google Scholar
• Foulds PG, Yokota O, Thurston A, et al. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson’s disease and Dementia with Lewy bodies. Neurobiol Dis. 2012;45:188–195.
   PubMed Web of Science ®Google Scholar
• Mejía M, Rodríguez-Leyva I, Cortés-Enríquez F, et al. Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study. J Neurol Sci. 2019;396:87–93.
   PubMed Web of Science ®Google Scholar
• Bilge N, Simsek F, Yevgi R, et al. Low serum Α-SYNUCLEIN and oligomer Α-SYNUCLEIN levels in multiple sclerosis patients. J Neuroimmunol. 2020;350:577432.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang K, Xu W, et al. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase. J Neurochem. 2012;122:19–23.
   PubMed Web of Science ®Google Scholar
• Ettle B, Kuhbandner K, Jörg S, et al. α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses. J Neuroinflammation. 2016;13:201.
   PubMed Web of Science ®Google Scholar
• Papadopoulos D, Ewans L, Pham-Dinh D, et al. Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease. Mol Cell Neurosci. 2006;31:597–612.
   PubMed Web of Science ®Google Scholar
• Zeydan B, Lowe VJ, Reichard RR, et al. Multiple sclerosis is associated with lower amyloid but normal tau burden on PET. Alzheimers Dement. 2020;16. DOI:10.1002/alz.039179
   Google Scholar
• Gehrmann J, Banati RB, Cuzner ML, et al. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia. 1995;15:141–151.
   PubMed Web of Science ®Google Scholar
• Sekiya H, Kowa H, Koga H, et al. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol. 2019;137:455–466.
   PubMed Web of Science ®Google Scholar
• Williams GP, Marmion DJ, Schonhoff AM, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855–874.
   PubMed Web of Science ®Google Scholar
• Piras IS, Bleul C, Schrauwen I, et al. Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease. Acta Neuropathol Commun. 2020;8:76.
   PubMed Web of Science ®Google Scholar